Elima K, Kaitila I, Mikonoja L, Elonsalo U, Peltonen L, Vuorio E
Department of Medical Biochemistry, University of Turku, Finland.
J Med Genet. 1989 May;26(5):314-9. doi: 10.1136/jmg.26.5.314.
The involvement of the cartilage specific type II collagen gene (COL2A1) was studied in nine patients with diastrophic dysplasia in the Finnish population, where the prevalence of this chondrodystrophy clearly exceeds that reported for other populations. COL2A1 was chosen as the candidate gene based on previous morphological and chemical studies which suggested abnormal structure of type II collagen in diastrophic dysplasia. Southern analysis of the patients' DNA showed no disease related differences in any of the restriction fragments covering the 30 kb COL2A1 gene. As a second approach, the nine patients and their 74 relatives were studied for the inheritance of the type II collagen gene. Three of the patients with diastrophic dysplasia were not homozygous for the intragenic RFLP markers, which suggests that the disease is not linked to the type II collagen gene. Multipoint linkage analysis gave a lod score of -2.95, which conclusively excluded the COL2A1 gene as the mutation site in diastrophic dysplasia in these families.
在芬兰人群中,对9例患脊柱骨骺发育不良的患者进行了软骨特异性II型胶原基因(COL2A1)的相关研究,该软骨发育不良在芬兰人群中的发病率明显高于其他人群。基于之前的形态学和化学研究表明脊柱骨骺发育不良中II型胶原结构异常,因此选择COL2A1作为候选基因。对患者的DNA进行Southern分析显示,覆盖30 kb COL2A1基因的任何限制性片段均未发现与疾病相关的差异。作为第二种方法,对9例患者及其74名亲属进行了II型胶原基因遗传研究。3例脊柱骨骺发育不良患者并非基因内限制性片段长度多态性(RFLP)标记的纯合子,这表明该疾病与II型胶原基因无关。多点连锁分析得出的优势对数(lod)分数为-2.95,最终排除了COL2A1基因是这些家族中脊柱骨骺发育不良的突变位点。